Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Piperazine | HCID 4837 | — |
| Reactant | Trifluoroacetic acid | HCID 6422 | — |
| Reactant | HCID 57794495 | HCID 57794495 | — |
| Solvent | Dimethyl Sulfoxide | HCID 679 | — |
| Product | HCID 86624995 | HCID 86624995 | — |
Reaction Steps
1-(2-(2,2,2-trifluoroethoxy)ethyl)-3-((2,2,2-trifluoroethylamino)methyl)-5-chloro-N-(pyrimidin-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-7-amine (213 mg, 0.41 mmol) prepared in Step 1 and piperazine (152 mg, 1.8 mmol) were mixed in dimethyl sulfoxide (3.0 ml) in a reaction vial. The reaction mixture was heated at 120° C. for 10 hours. The reaction was cooled to room temperature and brought to acidic condition by adding trifluoroacetic acid. The crude reaction mixture was purified by reverse phase HPLC (5-95% acetonitrile in water with 0.05% trifluoroacetic acid) and lyophilized to give the title compound as a dark yellow solid (70 mg).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07569572B2 |
|---|
| Source dataset | uspto-grants-2009_08 |
|---|
| ORD ID | ord-fc01ccf603f244d39e33112893188434 |
|---|
| Source note | uspto-grants-2009_08 |
|---|